Public Health Ontario, Public Health Laboratories, Toronto, Ontario, Canada.
J Clin Microbiol. 2012 Nov;50(11):3726-8. doi: 10.1128/JCM.00620-12. Epub 2012 Aug 15.
Pyrazinamide (PZA) is an important component of first-line therapy for the treatment of tuberculosis. Here, we evaluate targeted gene sequencing as a supplement to phenotypic PZA susceptibility testing of Mycobacterium tuberculosis. Routine sequencing of pncA, but not rpsA, is effective for verification of PZA susceptibility results.
吡嗪酰胺(PZA)是治疗结核病一线治疗方案中的重要组成部分。在这里,我们评估了靶向基因测序作为结核分枝杆菌表型 PZA 药敏试验的补充。常规测序 pncA 而不是 rpsA 可有效验证 PZA 药敏结果。